It is obvious that for any immunomodulatory strategy to be successful, further large placebo-controlled trials are needed. The criterion for these trials should be to clearly disclose at which ...

Pediatr Crit Care Med. 2013;14(6):e268-72. IV colistin was well tolerated in most of our critically ill children, and only five children had development of renal impairment after starting colistin ...